941294-19-5 Usage
Uses
Used in Pharmaceutical Industry:
(3-Bromo-5-nitrophenyl)(morpholino)methanone is used as a synthetic intermediate for the development of various pharmaceuticals, leveraging its unique chemical structure to contribute to the creation of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (3-Bromo-5-nitrophenyl)(morpholino)methanone is utilized as a precursor in the synthesis of agrochemicals, potentially enhancing crop protection and management through the development of novel compounds with pesticidal properties.
Used in Antimicrobial Applications:
(3-Bromo-5-nitrophenyl)(morpholino)methanone has been studied for its antimicrobial properties, making it a candidate for use as an antimicrobial agent in various applications, such as in the development of new antibiotics or disinfectants.
Used in Anticancer Research:
(3-Bromo-5-nitrophenyl)(morpholino)methanone is also being investigated for its potential anticancer properties, with the aim of identifying its role in inhibiting cancer cell growth or enhancing the effectiveness of existing cancer treatments.
Further research is ongoing to explore the potential applications of (3-Bromo-5-nitrophenyl)(morpholino)methanone in additional fields, given its unique chemical characteristics and the diverse possibilities it presents in both medicinal and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 941294-19-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,1,2,9 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 941294-19:
(8*9)+(7*4)+(6*1)+(5*2)+(4*9)+(3*4)+(2*1)+(1*9)=175
175 % 10 = 5
So 941294-19-5 is a valid CAS Registry Number.
941294-19-5Relevant articles and documents
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
-
Paragraph 00225, (2014/03/25)
The invention provides certain substituted phenyl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, Rcy, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
